Multicentre studies (Phase II-IV)

For evaluating the efficacy and tolerability of pharmaceuticals, a target orientated planning and conduct of multicentre trials phases II to IV are essential. Those are important milestones on the way to licensed new medications.

This is why it is our aspiration to find a tailored solution for our clients and accompany your product successfully from the start.

Product specified study designs within the legal guidelines and international directives, as well as a flexible project development and briefing are the basis of our partnership teamwork.